DBV Technologies (DBVT) Other Working Capital Changes (2018 - 2026)
DBV Technologies (DBVT) reported Other Working Capital Changes of -$600000.0 for Q1 2026, down 116.22% year-over-year from $3.7 million in Q1 2025, and down 138.1% on a QoQ basis from -$252000.0 in Q4 2025.
DBV Technologies (DBVT) has 9 years of Other Working Capital Changes data on file, last reported at -$600000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 116.22% year-over-year to -$600000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $399000.0 (up 107.66% YoY) and the FY2025 annual result came in at $4.7 million, up 201.51% from the prior year.
- Other Working Capital Changes eased to -$600000.0 in Q1 2026 per DBVT's latest filing, from -$252000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.7 million in Q1 2025 and bottomed at -$20.5 million in Q1 2022.
- The 5-year median for Other Working Capital Changes is -$61000.0 (2022), against an average of -$1.2 million.
- The widest annual swing landed in 2022, when Other Working Capital Changes sank 5006.0%; it then soared 343.11% in 2025.
- Tracing DBVT's Other Working Capital Changes over 5 years: stood at -$61000.0 in 2022, then sank by 3268.85% to -$2.1 million in 2023, then sank by 327.35% to -$8.8 million in 2024, then soared by 97.13% to -$252000.0 in 2025, then tumbled by 138.1% to -$600000.0 in 2026.
- Per Business Quant, the three latest DBVT Other Working Capital Changes figures stand at -$600000.0 (Q1 2026), -$252000.0 (Q4 2025), and $994000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -600,000.00 |
| Mar 31, 2026 | -600,000.00 |
| Dec 31, 2025 | -252,000.00 |
| Dec 31, 2025 | -252,000.00 |
| Sep 30, 2025 | 994,000.00 |
| Sep 30, 2025 | 994,000.00 |
| Jun 30, 2025 | 257,000.00 |
| Jun 30, 2025 | 257,000.00 |
| Mar 31, 2025 | 3.70 Mn |
| Mar 31, 2025 | 3.70 Mn |
| Dec 31, 2024 | -8.78 Mn |
| Dec 31, 2024 | -8.78 Mn |
| Sep 30, 2024 | -1.83 Mn |
| Sep 30, 2024 | -1.83 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | 835,000.00 |
| Mar 31, 2024 | 835,000.00 |
| Dec 31, 2023 | -2.06 Mn |
| Dec 31, 2023 | -2.06 Mn |
| Sep 30, 2023 | -631,000.00 |
| Sep 30, 2023 | -631,000.00 |
| Jun 30, 2023 | 3.38 Mn |
| Jun 30, 2023 | 3.38 Mn |
| Mar 31, 2023 | 3.10 Mn |
| Mar 31, 2023 | 3.10 Mn |
| Dec 31, 2022 | -61,000.00 |
| Dec 31, 2022 | -61,000.00 |
| Sep 30, 2022 | 2.54 Mn |
| Sep 30, 2022 | 2.54 Mn |
| Jun 30, 2022 | -2.98 Mn |
| Jun 30, 2022 | -2.98 Mn |
| Mar 31, 2022 | -20.46 Mn |
| Mar 31, 2022 | -20.46 Mn |
| Dec 31, 2021 | -458,000.00 |
| Dec 31, 2021 | -458,000.00 |
| Sep 30, 2021 | 643,000.00 |
| Sep 30, 2021 | 643,000.00 |
| Jun 30, 2021 | 7.98 Mn |
| Jun 30, 2021 | 7.98 Mn |
| Mar 31, 2021 | 417,000.00 |
| Mar 31, 2021 | 417,000.00 |
| Dec 31, 2020 | -316,000.00 |
| Dec 31, 2020 | -316,000.00 |
| Sep 30, 2020 | 2.58 Mn |
| Sep 30, 2020 | 2.58 Mn |
| Jun 30, 2020 | 7.14 Mn |
| Jun 30, 2020 | 7.14 Mn |
| Mar 31, 2020 | -122,000.00 |
| Mar 31, 2020 | -122,000.00 |
| Sep 30, 2019 | -8.94 Mn |
| Sep 30, 2019 | -8.94 Mn |
| Sep 30, 2018 | -17.42 Mn |
| Sep 30, 2018 | -17.42 Mn |